News for the ‘Digitek Legal’ Category

Caraco brand digoxin recalled; could put consumers at risk

Caraco Pharmaceutical Laboratories has alerted the Food and Drug Administration (FDA) and is issuing a consumer-level recall of all tablets of the generic medication Caraco brand Digoxin, USP, 0.125 mg, and Digoxin, USP, 0.25 mg, distributed prior to March 31, 2009, which are not expired and are within the expiration date of September, 2011. The drugs are being voluntarily recalled. The tablets may differ in size and could contain more or less of the active ingredient, digoxin.

Read the rest of this entry »

Those suing for Digitek injury must fill out lengthy fact sheets

Individuals suing manufacturers of Digitek heart medicine must fill out lengthy and detailed fact sheets on their medical history and allow no secrets from their past, according to The West Virginia Record.

The fact sheets will be used in court to determine whether Mylan Pharmaceuticals of West Virginia, Actavis US and DUL Laboratories misrepresented Digitek as safe and whether physicians and patients relied on those “misrepresentations and deceptions” in choosing to use the heart medicine.

Read the rest of this entry »

Texas woman sues Digitek manufacturer for husband’s death

A woman from Texas that her husband died in January 2007 as a result of his Digitek medication containing twice the active ingredient. On Jan. 23, 2008, Vickie Butts, representing the estate of her deceased husband, Donnie Butts, filed a product liability lawsuit against Actavis, the drug manufacturer, and Mylan, the distributor.

Read the rest of this entry »

Alabama man dies after consuming Digitek

Nicholas Chandler, a 23-year-old resident of Alabama, died after consuming Digitek (Digozin) on Jan. 9, 2009. His doctor prescribed Digitek (Digozin) in order to correct his heart condition that could not be corrected by other medications. Chandler suffered toxicity after taking the medication.

Chandler’s wife Barbara Chandler deems the defendants negligent because Digitek was distributed to the public with twice the amount of the active ingredient, according to the West Virginia Record.

The paper reports, “Digitek (Digozin) has a narrow therapeutic index and has a limited margin between effectiveness and toxicity. Chandler, as administratix of the estate is seeking judgment, jointly and severly, (sic.) from all defendants, pre and post judgment interest and costs.”

FDA awaits Actavis permanent injunction

The drug company Actavis, producer of the heart drug Digitek, agreed to close several plants in New Jersey and will not resume operations at these plants until U.S. standards for testing and manufacturing have been met by the FDA. According to Pharma Tech Live, the FDA has filed a consent degree, banning from distributing drugs in Totowa and Little Falls, N.J. The agreement also gives the FDA the right to close the plants if violations persist and to fine the company $15,000 a day afterward.

Read the rest of this entry »

Actavis N.J. plant agrees with FDA

Actavis Inc. has made an agreement with the FDA not to issue any drugs from its Totowa facilities in Morristown, N.J., where Digitek is produced.

According to the Philadelphia Inquirer, the agreement says cannot resume its practices until it conforms to “the agency’s good manufacturing practice.” must improve its labs, facilities, and equipment.

has faced numerous lawsuits over the recalled drug Digitek. One such lawsuit includes the death of a patient and that Digitek is an unsafe and flawed drug.

would not comment if the FDA agreement had influenced the Digitek lawsuits or not.

Goodwin to seperate federal digitek complaints

U.S. District Judge Joseph Goodwin, who is striving to resolve the national litigation over Digitek, wants separate complaints from separate plaintiffs. On December 2, he signed an order stating that all Digitek attorneys who have numerous plaintiffs in single suits must separate the .

Read the rest of this entry »

Kentucky man files digitek suit after losing wife

John Anthony Conte of Madison County, Kentucky, filed a Digitek lawsuit against a West Virginia pharmaceutical company, Mylan Pharmaceuticals, for his wife’s estate. His wife is believed to have died after taking Digitek. This suit was filed on October 9, 2008.

Read the rest of this entry »

Actavis comments on lawsuit

The Department of Justice, on behalf of the FDA, has filed a compliant against Actavis and is asking for a permanent injunction against its subsidiary.

Read the rest of this entry »

U.S. attorneys sue makers of Digitek, seek to close facilities

U.S. Attorneys in New Jersey are moving to close three Actavis Inc. plants, the company that manufactures Digitek, until they comply with FDA regulations.

Read the rest of this entry »